Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Notes Payables (2016 - 2017)

Historic Notes Payables for Editas Medicine (EDIT) over the last 2 years, with Q4 2017 value amounting to $7.5 million.

  • Editas Medicine's Notes Payables fell 2500.0% to $7.5 million in Q4 2017 from the same period last year, while for Dec 2017 it was $7.5 million, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $7.5 million for FY2017, which is 2500.0% down from last year.
  • Per Editas Medicine's latest filing, its Notes Payables stood at $7.5 million for Q4 2017, which was down 2500.0% from $15.0 million recorded in Q2 2017.
  • Editas Medicine's 5-year Notes Payables high stood at $15.0 million for Q1 2017, and its period low was $7.5 million during Q4 2017.